帕利佩里纳米晶的开发用于治疗精神分裂症
Phattalapol Lhaglham1,2,3, Luksika Jiramonai1,2, Xing-Jie Liang1,2
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, People's Republic of China.
Progress in biomedical engineering (Bristol, England)
|December 10, 2024
概括
由于口服抗精神病药物不坚持,精神分裂症的治疗面临挑战. 帕利佩里纳米晶可以改善精神分裂症管理的坚持和结果,展示纳米技术.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 纳米技术 纳米技术
背景情况:
- 精神分裂症是一种衰弱的慢性精神疾病,发病率不断上升.
- 目前的口服抗精神病药因患者不良坚持治疗,导致复发率高 (超过80%).
- 经常服用口服抗精神病药物是治疗坚持的主要障碍.
研究的目的:
- 审查精神分裂症,其原因,以及当前的治疗挑战.
- 探索纳米晶体技术在抗精神病药物开发中的应用.
- 突出帕利佩里纳米晶在精神分裂症管理中的临床优势.
主要方法:
- 审查关于精神分裂症和抗精神病治疗的现有文献.
- 探索纳米晶体技术原理和药物配方.
- 对临床数据和与paliperidone纳米晶相关的结果的分析.
主要成果:
- 帕利佩里纳米晶体代表了一种成功的长效抗精神病药物配方.
- 临床优势包括改善的坚持性,疗效,患者满意度和成本效益.
- 影响药物半衰期的物理化学因素对于长效配方至关重要.
结论:
- 纳米晶体技术为开发治疗精神分裂症的有效长效药物提供了一个有希望的方法.
- 帕利佩里纳米晶体显示出改善患者治疗结果和治疗慢性疾病的巨大潜力.
- 对基于纳米晶体的长效药物的进一步研究对于提高治疗可靠性至关重要.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
01:28Psychosis and Antipsychotic Drugs: Overview
176
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
176
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
453
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
453
01:21Antipsychotic Drugs: Typical and Atypical Agents
156
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
156